The global cryptococcosis market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The major factors that are expected to accelerate the growth of the market during the forecast period include the growing prevalence of cryptococcosis and the availability of advanced treatment. Cryptococcosis is a fungal infection which is caused by cryptococcus neoformans and Cryptococcus gattii which primarily affect the central nervous system and the lungs. People with diseases such as AIDS, Hodgkin lymphoma, other lymphomas, sarcoidosis, and solid organ transplantation with weakened immune systems are generally more susceptible to this type of infection. Cryptococcosis is usually acquired by inhalation of dust-containing yeast cells which typically affects the lungs.
To Request a Sample of our Report on Global Cryptococcosis Market: https://www.omrglobal.com/request-sample/cryptococcosis-market
Cryptococcosis symptoms include fever, malaise, cough, hemoptysis (bloody or blood-tinged sputum), headache, vision changes (blurry or double vision, photophobia), and so on. Cryptococcosis diagnosis is clinical and microscopic, which is confirmed by culture or fixed-tissue staining. According to the United Nations Program on HIV/AIDS and the World Health Organization (WHO), globally approximately one million cases of cryptococcosis are reported each year resulting in 625,000 mortalities approximately. According to the Centers for Disease Control and Prevention and WHO, it is estimated that globally every year 220,000 cases of cryptococcal meningitis occur among people with HIV/AIDS, resulting in nearly 181,000 mortalities. However, adverse effects associated with the use of medication is likely to restrain the market growth.
Cryptococcosis infects humans and animals, usually by inhalation of the fungus, which results in lung infection that may spread to the brain, causing meningoencephalitis. Flucytosine is a small, water-soluble molecule that is a nucleoside analog antifungal drug that acts by disrupting pyrimidine metabolism in the fungal cell nucleus. Flucytosine is generally given as first-line treatment in combination with other antifungal medications. Flucytosine was major revenue holding segment because it is given as a first-line treatment in combination with other antifungal medications. According to the United Nations Program on HIV/AIDS and the World Health Organization, globally approximately one million cases of cryptococcosis are reported each year resulting in 625,000 mortalities approximately. The increasing prevalence of cryptococcosis and increasing new and advanced treatment opportunities are the key factors that are boosting the growth of the market during the forecast period.
(Get 15% Discount on Buying this Report)
A full Report of Global Cryptococcosis Market is Available at: https://www.omrglobal.com/industry-reports/cryptococcosis-market
Global Cryptococcosis Market Report by Segment
· By Treatment
· Amphotericin B
· Flucytosine
· Fluconazole
· Others
Global Cryptococcosis Market by Region
North America
· United States
· Canada
Europe
· UK
· Germany
· Spain
· France
· Italy
· Rest of Europe
Asia-Pacific
· India
· China
· Japan
· South Korea
· Rest of APAC
Rest of the World
· Latin America
· Middle East & Africa
Reasons to buy from us –
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
(This release has been published on Global Market Post. Global Market Post is not responsible for any content included in this release.)
